Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 9 studies | 31% ± 10% | |
| squamous epithelial cell | 4 studies | 27% ± 16% | |
| naive B cell | 4 studies | 18% ± 2% | |
| endothelial cell | 4 studies | 20% ± 1% | |
| epithelial cell | 4 studies | 26% ± 5% | |
| erythrocyte | 3 studies | 26% ± 10% | |
| B cell | 3 studies | 28% ± 8% | |
| CD4-positive, alpha-beta T cell | 3 studies | 22% ± 6% | |
| GABAergic neuron | 3 studies | 25% ± 4% | |
| endothelial cell of lymphatic vessel | 3 studies | 19% ± 3% | |
| astrocyte | 3 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 30% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 863.27 | 1438 / 1445 | 99% | 7.06 | 182 / 183 |
| lung | 100% | 804.84 | 577 / 578 | 98% | 4.73 | 1131 / 1155 |
| kidney | 99% | 326.09 | 88 / 89 | 92% | 4.81 | 832 / 901 |
| breast | 100% | 688.23 | 457 / 459 | 92% | 4.25 | 1023 / 1118 |
| thymus | 100% | 852.29 | 653 / 653 | 89% | 3.81 | 537 / 605 |
| ovary | 99% | 608.51 | 178 / 180 | 90% | 3.39 | 386 / 430 |
| stomach | 100% | 549.99 | 358 / 359 | 87% | 3.48 | 250 / 286 |
| intestine | 100% | 651.67 | 965 / 966 | 87% | 2.75 | 459 / 527 |
| pancreas | 92% | 294.25 | 301 / 328 | 91% | 3.14 | 162 / 178 |
| prostate | 98% | 434.08 | 239 / 245 | 84% | 2.93 | 424 / 502 |
| brain | 85% | 300.58 | 2253 / 2642 | 97% | 4.95 | 681 / 705 |
| bladder | 95% | 541.38 | 20 / 21 | 84% | 2.67 | 423 / 504 |
| uterus | 99% | 687.36 | 169 / 170 | 75% | 2.21 | 344 / 459 |
| adrenal gland | 98% | 710.29 | 252 / 258 | 73% | 1.90 | 168 / 230 |
| skin | 98% | 892.53 | 1778 / 1809 | 71% | 1.70 | 333 / 472 |
| spleen | 100% | 664.56 | 241 / 241 | 0% | 0 | 0 / 0 |
| muscle | 100% | 746.09 | 802 / 803 | 0% | 0 | 0 / 0 |
| adipose | 100% | 649.80 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 433.61 | 1321 / 1335 | 0% | 0 | 0 / 0 |
| liver | 55% | 116.94 | 124 / 226 | 44% | 0.90 | 178 / 406 |
| peripheral blood | 97% | 1137.24 | 898 / 929 | 0% | 0 | 0 / 0 |
| heart | 95% | 793.61 | 820 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 3.73 | 40 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 1.61 | 17 / 29 |
| eye | 0% | 0 | 0 / 0 | 20% | 0.30 | 16 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0014812 | Biological process | muscle cell migration |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TCP11L2 |
| Protein name | T-complex protein 11-like protein 2 T-complex 11 (Mouse) like 2, isoform CRA_c (T-complex 11 like 2) Alternative protein TCP11L2 T-complex 11 like 2 |
| Synonyms | hCG_1813015 |
| Description | FUNCTION: Promotes the migration of muscle-derived satellite cells (MDSCs) during differentiation throught interaction with FMNL2 and therefore may participate in microfilament assembly. . |
| Accessions | ENST00000551228.1 ENST00000547153.5 [Q8N4U5-2] ENST00000549906.5 F8VW27 F8VRQ3 F8W1M6 ENST00000553143.5 L8E978 ENST00000299045.8 [Q8N4U5-1] G3V1Z2 F8VU20 ENST00000546625.5 F8W0R5 ENST00000551802.5 Q8N4U5 ENST00000553098.5 ENST00000548428.1 |
